Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

InMed Pharmaceuticals - 12 Year Stock Price History | INM

Historical daily share price chart and data for InMed Pharmaceuticals since 2013 adjusted for splits and dividends. The latest closing stock price for InMed Pharmaceuticals as of July 23, 2025 is 2.69.
  • The all-time high InMed Pharmaceuticals stock closing price was 31181.90 on January 03, 2018.
  • The InMed Pharmaceuticals 52-week high stock price is 15.70, which is 483.6% above the current share price.
  • The InMed Pharmaceuticals 52-week low stock price is 1.72, which is 36.1% below the current share price.
  • The average InMed Pharmaceuticals stock price for the last 52 weeks is 3.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
InMed Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.0220 4.8000 5.0500 1.8600 2.6900 -43.25%
2024 5.7297 7.8000 8.8000 2.4520 4.7400 -43.03%
2023 21.0710 44.2000 46.0000 6.5980 8.3200 -79.41%
2022 288.1619 680.0000 680.0000 26.4000 40.4000 -93.83%
2021 1405.4002 1745.0000 2675.0000 655.0000 655.0000 -60.18%
2020 2681.0262 3134.6900 4850.5200 1487.5000 1645.0000 -44.61%
2019 4910.4757 4779.5700 9849.5200 2887.2100 2969.7000 -29.40%
2018 12077.9427 23630.6000 31181.9000 3792.9700 4206.1100 -76.05%
2017 6163.9259 2969.7000 17564.2000 2889.3600 17564.2000 526.24%
2016 1631.8703 1913.8100 3233.6800 824.9170 2804.7200 47.83%
2015 2652.4540 1979.8000 5058.3900 1443.6100 1897.3100 -4.17%
2014 4520.4915 4388.5600 10525.9000 1656.4400 1979.8000 344.44%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.005B
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.891B 28.47
Zoetis (ZTS) United States $67.311B 25.11
Takeda Pharmaceutical (TAK) Japan $46.297B 9.21
Daiichi Sankyo, - (DSNKY) Japan $45.521B 23.33
BeOne Medicines - (ONC) Cayman Islands $32.397B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.766B 0.00
Summit Therapeutics (SMMT) United States $19.710B 0.00
Merck (MKKGY) Germany $16.653B 12.20
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.437B 11.89
Neurocrine Biosciences (NBIX) United States $13.138B 45.00
Orion OYJ (ORINY) Finland $11.666B 28.12
IPSEN (IPSEY) France $10.323B 0.00
Stevanato Group S.p.A (STVN) Italy $7.420B 45.37
Corcept Therapeutics (CORT) United States $7.326B 59.55
Madrigal Pharmaceuticals (MDGL) United States $6.959B 0.00
Ionis Pharmaceuticals (IONS) United States $6.677B 0.00
Grifols, S.A (GRFS) Spain $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.335B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
Hypermarcas (HYPMY) Brazil $3.034B 19.96
Crinetics Pharmaceuticals (CRNX) United States $2.853B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.574B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.549B 8.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
Centessa Pharmaceuticals (CNTA) United Kingdom $2.160B 0.00
Ocular Therapeutix (OCUL) United States $1.840B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.810B 0.00
ARS Pharmaceuticals (SPRY) United States $1.728B 0.00
Endo (NDOI) United States $1.603B 0.00
Harrow (HROW) United States $1.325B 0.00
Evotec AG (EVO) Germany $1.321B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 24.00
Avadel Pharmaceuticals (AVDL) Ireland $1.086B 0.00
Ardelyx (ARDX) United States $1.059B 0.00
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.047B 0.00
Collegium Pharmaceutical (COLL) United States $1.017B 5.48
Akebia Therapeutics (AKBA) United States $1.011B 0.00
Verve Therapeutics (VERV) United States $0.988B 0.00
ProKidney (PROK) United States $0.893B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.790B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.702B 0.00
Xencor (XNCR) United States $0.655B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Zevra Therapeutics (ZVRA) United States $0.633B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
USANA Health Sciences (USNA) United States $0.587B 11.81
Theravance Biopharma (TBPH) United States $0.562B 0.00
Bioventus (BVS) United States $0.529B 13.42
Oruka Therapeutics (ORKA) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.484B 0.00
Savara (SVRA) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 9.69
Altimmune (ALT) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
AleAnna (ANNA) United States $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.37
OmniAb (OABI) United States $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.240B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
China SXT Pharmaceuticals (SXTC) China $0.204B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
Profound Medical (PROF) Canada $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Lyell Immunopharma (LYEL) United States $0.152B 0.00
Liminatus Pharma (LIMN) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Nutriband (NTRB) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.026B 0.00
Incannex Healthcare (IXHL) Australia $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.41
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.46
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00